Inflammatory cytokines such as IL-6, IL-17, and IL-11 play a vital role in shaping cell plasticity within the TME and enhancing tumor cell proliferation, particularly under sub-optimal in vivo conditions such as hypoxia, nutrient deficiency, and limited production of growth factors, while also counteracting anti-tumor immunity (58, 145). Here, IL11 is linked to neoplasm.